Melanoma and skin cancers at ASCO 2027
Jun 4–8, 2027 Chicago, IL ~44k attendees Website
7 organizations at ASCO 2027 present work in melanoma and skin cancers. 7 of them have their own page in this guide. As of Oct 8, 2026.
Showing 1–7 of 7 organizations
| Organization | ASCO 2027 Attendance |
|---|---|
IDEAYA Biosciences South San Francisco, CA | |
Precision oncology biotech whose lead drug darovasertib targets uveal melanoma in metastatic and neoadjuvant settings, alongside other synthetic lethality programs. | Booth Exhibiting at Booth 26001 |
Immunocore Abingdon, UK | |
Commercial-stage biotech behind Kimmtrak (tebentafusp), the first approved T cell receptor therapy, for uveal melanoma; developing more bispecific TCR drugs. | Booth Exhibiting at Booth 25157 |
Iovance Biotherapeutics San Carlos, CA | |
Cell therapy company marketing Amtagvi, a tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma, and testing TIL therapy in other solid tumors. | Booth Exhibiting at Booth 19149 |
Moderna Cambridge, MA | |
mRNA medicines company developing individualized cancer vaccines, including intismeran autogene with Merck for melanoma, alongside infectious disease vaccines. | Booth Exhibiting at Booth 24149 |
Pierre Fabre Lavaur, France | |
French pharmaceutical and dermo-cosmetics company with targeted cancer therapies for melanoma, colorectal and lung cancers, plus breast and hematology medicines. | Booth Exhibiting at Booth 27034 |
Regeneron Sleepy Hollow, NY | |
Biotechnology drugmaker whose cancer medicines include cemiplimab (Libtayo) for skin and lung cancers and bispecific antibodies for myeloma and lymphoma. | Booth Exhibiting at Booth 11111 |
Replimune Woburn, MA | |
Biotech developing oncolytic immunotherapies built on an engineered herpes simplex virus, led by RP1 for advanced melanoma. | Booth Exhibiting at Booth 31165 |
Instantly find 20 buyers in melanoma and skin cancers
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse ASCO 2027 by
Organization type
Focus
- Clinical trials 58
- Biomarkers and genomics 44
- AI and data 38
- Blood cancers 36
- Lung cancer 28
- Genitourinary cancers 24
- Gastrointestinal cancers 21
- Breast cancer 18
- Immunotherapy 17
- Imaging and radiation 17
- Patient support and survivorship 14
- Antibody-drug conjugates 9
- Cell and gene therapy 8
- Melanoma and skin cancers 7
- Gynecologic cancers 6
Exhibit hall
Everyone
Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction